DK1645558T3 - Piperazinylpyraziner som serotonin 5-HT2C receptormodulatorer - Google Patents

Piperazinylpyraziner som serotonin 5-HT2C receptormodulatorer

Info

Publication number
DK1645558T3
DK1645558T3 DK05023471T DK05023471T DK1645558T3 DK 1645558 T3 DK1645558 T3 DK 1645558T3 DK 05023471 T DK05023471 T DK 05023471T DK 05023471 T DK05023471 T DK 05023471T DK 1645558 T3 DK1645558 T3 DK 1645558T3
Authority
DK
Denmark
Prior art keywords
serotonin
piperazinylpyrazines
receptor modulators
ht2c receptor
relates
Prior art date
Application number
DK05023471T
Other languages
English (en)
Inventor
Magnus Cernerud
Helena Lundstroem
Claes Loefstroem
Margit Pelcman
Tom Fleck
Alexander Paptchikhine
Emma Andersson
Alf Nygren
Original Assignee
Biovitrum Ab Publ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0201881A external-priority patent/SE0201881D0/xx
Priority claimed from SE0202041A external-priority patent/SE0202041D0/xx
Priority claimed from SE0202516A external-priority patent/SE0202516D0/xx
Application filed by Biovitrum Ab Publ filed Critical Biovitrum Ab Publ
Application granted granted Critical
Publication of DK1645558T3 publication Critical patent/DK1645558T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Pyridine Compounds (AREA)
  • Luminescent Compositions (AREA)
DK05023471T 2002-06-19 2003-06-18 Piperazinylpyraziner som serotonin 5-HT2C receptormodulatorer DK1645558T3 (da)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
SE0201881A SE0201881D0 (sv) 2002-06-19 2002-06-19 Novel compounds, their use, and preparation
US39065602P 2002-06-21 2002-06-21
SE0202041A SE0202041D0 (sv) 2002-06-28 2002-06-28 Novel process
US40611902P 2002-08-26 2002-08-26
SE0202516A SE0202516D0 (sv) 2002-08-26 2002-08-26 Novel compounds, their use, and preparation
US41670102P 2002-10-07 2002-10-07
PCT/SE2003/001043 WO2004000829A1 (en) 2002-06-19 2003-06-18 Novel process

Publications (1)

Publication Number Publication Date
DK1645558T3 true DK1645558T3 (da) 2008-10-06

Family

ID=30004077

Family Applications (2)

Application Number Title Priority Date Filing Date
DK03736405T DK1529043T3 (da) 2002-06-19 2003-06-18 Fremgangsmåde til fremstilling af 2-methylpiperazin-derivater
DK05023471T DK1645558T3 (da) 2002-06-19 2003-06-18 Piperazinylpyraziner som serotonin 5-HT2C receptormodulatorer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK03736405T DK1529043T3 (da) 2002-06-19 2003-06-18 Fremgangsmåde til fremstilling af 2-methylpiperazin-derivater

Country Status (16)

Country Link
EP (2) EP1529043B1 (da)
JP (4) JP4592417B2 (da)
CN (1) CN100334082C (da)
AT (2) ATE398119T1 (da)
AU (1) AU2003237746B8 (da)
CA (1) CA2485532C (da)
CY (1) CY1106225T1 (da)
DE (2) DE60307286T2 (da)
DK (2) DK1529043T3 (da)
ES (2) ES2270051T3 (da)
HK (1) HK1080079B (da)
NO (1) NO20050279D0 (da)
NZ (1) NZ536663A (da)
PT (2) PT1529043E (da)
SI (2) SI1645558T1 (da)
WO (1) WO2004000829A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1792629A4 (en) 2004-08-25 2010-08-25 Takeda Pharmaceutical PREVENTIVE / REMEDY AGENTS FOR INCONTINENCE OF STRESS AND SELECETING METHOD THEREOF
EP2018863B9 (en) 2006-05-16 2015-02-18 Takeda Pharmaceutical Company Limited Fused heterocyclic compound and use thereof
JP5317354B2 (ja) 2007-10-16 2013-10-16 第一三共株式会社 ピリミジルインドリン化合物
US20100266504A1 (en) 2007-11-15 2010-10-21 Takahiro Matsumoto Condensed pyridine derivative and use thereof
CA2765239C (en) 2009-06-15 2018-08-07 Takeda Pharmaceutical Company Limited Pyrazinooxazepine derivatives
JPWO2011071136A1 (ja) 2009-12-11 2013-04-22 アステラス製薬株式会社 線維筋痛症治療剤
GB201304811D0 (en) * 2013-03-15 2013-05-01 Proximagen Ltd Novel treatment for hypertension
JPWO2019131902A1 (ja) 2017-12-27 2020-12-10 武田薬品工業株式会社 腹圧性尿失禁および便失禁の治療薬

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06306075A (ja) * 1993-04-23 1994-11-01 Sanwa Kagaku Kenkyusho Co Ltd エトキシベンズアミド誘導体
CN1242995C (zh) * 1999-05-21 2006-02-22 比奥维特罗姆股份公司 化合物,它们的用途和制备方法
AR032318A1 (es) * 2000-04-13 2003-11-05 Pharmacia Corp Compuesto derivado halogenado del acido 2-amino-5,6 heptenoico; composicion farmaceutica que lo comprende y su uso en la fabricacion de un medicamento util como inhibidor de la oxido nitrico sintetasa
CN1227237C (zh) * 2000-11-20 2005-11-16 比奥维特罗姆股份公司 作为五羟色胺5－ht2受体拮抗剂的哌嗪基吡嗪化合物

Also Published As

Publication number Publication date
CA2485532A1 (en) 2003-12-31
PT1529043E (pt) 2006-12-29
ATE334980T1 (de) 2006-08-15
JP4592417B2 (ja) 2010-12-01
NZ536663A (en) 2007-05-31
DE60307286D1 (de) 2006-09-14
SI1645558T1 (sl) 2008-10-31
AU2003237746B8 (en) 2010-01-28
AU2003237746A1 (en) 2004-01-06
JP2013227336A (ja) 2013-11-07
CY1106225T1 (el) 2011-06-08
EP1529043A1 (en) 2005-05-11
JP5378241B2 (ja) 2013-12-25
ES2270051T3 (es) 2007-04-01
JP2010120949A (ja) 2010-06-03
WO2004000829A1 (en) 2003-12-31
NO20050279D0 (no) 2005-01-18
CN100334082C (zh) 2007-08-29
DK1529043T3 (da) 2006-12-04
EP1645558A1 (en) 2006-04-12
ES2307102T3 (es) 2008-11-16
PT1645558E (pt) 2008-07-30
CN1662523A (zh) 2005-08-31
JP2013116906A (ja) 2013-06-13
HK1080079A1 (en) 2006-04-21
EP1529043B1 (en) 2006-08-02
JP2005537316A (ja) 2005-12-08
DE60307286T2 (de) 2007-10-25
EP1645558B1 (en) 2008-06-11
AU2003237746B2 (en) 2009-12-17
HK1080079B (zh) 2008-03-14
SI1529043T1 (sl) 2006-12-31
CA2485532C (en) 2012-03-06
DE60321606D1 (de) 2008-07-24
ATE398119T1 (de) 2008-07-15

Similar Documents

Publication Publication Date Title
BR0311494A (pt) Novos indóis substituìdos
SE0303180D0 (sv) Novel compounds
SE0302232D0 (sv) Novel Compounds
SE0202241D0 (sv) Novel Compounds
BRPI0410711A (pt) novos compostos
SE0502254L (sv) Nya disubstituerade fenyl-piperidiner som modulatorer för dopaminneurotransmission
DK1694318T3 (da) (S)-2-N-propylamino-5-hydroxytetralin som D3-agonistisk terapeutikum
DK1379246T3 (da) Nocieptin-analoger
PA8493701A1 (es) Compuestos para tratar la obesidad
NO20063275L (no) Anvendelse av substituerte 2-aminotetraliner for forebyggende behandling av Parkinsons sykdom
EA200601798A1 (ru) Замещенные соединения морфолина для лечения расстройств центральной нервной системы
NO20062139L (no) Dihydrobenzofuranyl-alkanaminderivater som 5HT2C-agonister
EA200970326A1 (ru) Алкильные производные в качестве метаботропных рецепторов глутамата
EA200700909A1 (ru) Азаиндолкарбоксамиды
EA200601194A1 (ru) Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором
ECSP034811A (es) Derivados heterocicliloxi-, -tioxi - y - aminobenzazole tales como ligandos 5-hidroxitriptamina-6
DK1461318T3 (da) Tetrahydroquinolinanaloge som muscariniske agonister
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
HK1080079A1 (en) A process for the preparation of 2-methylpiperazine derivative
SE0401465D0 (sv) New substituted piperdines as modulators of dopamine neurotransmission
HK1106494A1 (en) Aminomethyl substituted bicyclic aromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
EA200602081A1 (ru) Пиридиновые производные алкилоксиндолов в качестве агентов, активных в отношении рецептора 5-нт7
DK1301475T3 (da) Arylsulfonamider, som serotoninantagonist til behandling af obesitet
ATE418973T1 (de) Spirocyclopropyl-amide und -säuren und ihre therapeutischen anwendungen
DK1558610T3 (da) Substituerede aminoquinuclidinforbindelser og deres anvendelse som delta-opioidreceptorligander